Fig. 2: Proportion of thromboembolic events in each study that occurred when patients' INRs were below the therapeutic range, with summary estimates from the random-effects meta-analysis.
Fig. 2: Proportion of thromboembolic events in each study that occurred when patients' INRs were below the therapeutic range, with summary estimates from the random-effects meta-analysis.